.png)
JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation | 131 |
Total Visits Per Month
| December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | |
|---|---|---|---|---|---|---|---|
| Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation | 0 | 0 | 2 | 1 | 3 | 15 | 3 |
File Visits
| Views | |
|---|---|
| Dzeshka_Expert opinion on drug safety_Warfarin versus dabigatran_repository.pdf | 178 |
Top country views
| Views | |
|---|---|
| United States | 50 |
| Russia | 17 |
| Sweden | 9 |
| Canada | 6 |
| United Kingdom | 6 |
| Austria | 5 |
| Switzerland | 4 |
| China | 4 |
| Poland | 4 |
| Ukraine | 4 |
Top cities views
| Views | |
|---|---|
| Oakland | 11 |
| Moscow | 6 |
| Ottawa | 6 |
| Mountain View | 5 |
| Vienna | 5 |
| Andover | 4 |
| Ann Arbor | 4 |
| Ashburn | 4 |
| Basel | 4 |
| Menlo Park | 4 |